Body aches as worsened; headache was reported as worsened; This non-serious case was reported by a other health professional via sales rep and described the occurrence of general body pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On 13-JAN-2025, the patient received Shingrix. In JAN-2025, an unknown time after receiving Shingrix, the patient experienced general body pain (Verbatim: Body aches as worsened) and headache (Verbatim: headache was reported as worsened). The outcome of the general body pain and headache were not resolved. The reporter considered the general body pain and headache to be related to Shingrix. The company considered the general body pain and headache to be related to Shingrix. Additional Information: GSK Receipt Date: 14-JAN-2025 The patient received Shingrix and had body aches and headache. Body aches and headache was reported as worsened. The patient had subsequent dose of Shingrix.